**Key Developments**: - Hong Kong Exchanges and Clearing (00388) plans a strategic investment in Xunqing Clearing Holdings Limited. - Laekna Therapeutics-B (02105) signed an exclusive licensing agreement with Qilu Pharmaceutical for LAE 002 (AFURESERTIB) in China. - TECHSTARACQ-Z (07855) expects its successor company, TuSimple, to list on the Main Board of the Stock Exchange on December 10. - Superstar Legend (06683) intends to establish a joint venture with Unitree Robotics to develop consumer-grade IP robots and derivative products. - Beijing Enterprises Holdings (00392) plans to acquire 100% equity of Beijing Beiran Special Equipment Inspection and Testing Co., Ltd. for RMB 54.6 million. - CSPC Pharmaceutical (01093) announced that the marketing application for pertuzumab injection has been accepted by China's National Medical Products Administration. - **WING LEE DEV (09639) proposes collaboration with CATL to jointly develop high-efficiency energy storage systems and solutions.**

**Operational Performance**: - BeiGene (06160) reported a net profit attributable to shareholders of RMB 1.139 billion for the first three quarters, turning losses into gains year-on-year. - Tencent Music-SW (01698) posted a Q3 net profit attributable to equity holders of RMB 2.15 billion, up 36.0% YoY. - Chow Tai Fook (06168) saw e-commerce revenue grow 32% and net profit rise 71% YoY in the first 10 months. - China Resources Land (01109) recorded contracted sales of approximately RMB 169.6 billion in the first 10 months, down 16.6% YoY.